Related references
Note: Only part of the references are listed.FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
Zixin Guo et al.
FRONTIERS IN ONCOLOGY (2021)
Genomic Analyses of Metaplastic or Sarcomatoid Carcinomas From Different Organs Revealed Frequent Mutations in KMT2D
Biqiang Zheng et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
Simone Ferrero et al.
HAEMATOLOGICA (2020)
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
M. Moehler et al.
ANNALS OF ONCOLOGY (2020)
Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Yongping Cui et al.
CELL RESEARCH (2020)
High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma
Yanfen Feng et al.
BMC CANCER (2020)
RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Advances in targeted therapy for esophageal cancer
Yan-Ming Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The Function of RAS Mutation in Cancer and Advances in its Drug Research
Shijie Chen et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Gastrointestinal Stromal Tumors of the Stomach and Esophagus
Lauren Theiss et al.
SURGICAL CLINICS OF NORTH AMERICA (2019)
Rap1A promotes esophageal squamous cell carcinoma metastasis through the AKT signaling pathway
Qinfang Li et al.
ONCOLOGY REPORTS (2019)
RasGRP3, a Ras guanyl releasing protein 3 that contributes to malignant proliferation and aggressiveness in human esophageal squamous cell carcinoma
Ziteng Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
Epidemiology of Esophageal Squamous Cell Carcinoma
Christian C. Abnet et al.
GASTROENTEROLOGY (2018)
Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species
Yuki Kitano et al.
JOURNAL OF PATHOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Therapeutic strategies to target RAS-mutant cancers
Meagan B. Ryan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis
Yan-Fen Feng et al.
CELL DEATH & DISEASE (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu et al.
CELL (2017)
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action
Julien Masliah-Planchon et al.
ONCOTARGET (2016)
Biostatistics Series Module 3: Comparing Groups: Numerical Variables
Avijit Hazra et al.
INDIAN JOURNAL OF DERMATOLOGY (2016)
Global incidence of oesophageal cancer by histological subtype in 2012
Melina Arnold et al.
GUT (2015)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Share Paper
